ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Garb’s Questions, Answers About Cancer Program

December 5, 1980

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

Toxicity Of Salts Regimen Should Remain A Concern.

January 4, 2002

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

Patient’s Husband Had Idea to Use Avastin For Glioblastoma

April 3, 2009

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test

March 28, 2014